Adverum Biotechnologies, Inc. Stock Chart

Adverum Biotechnologies, Inc. (LSE) · Health Technology. stock live price and technical analysis view. Follow LSE data on Alerta Chart.

Checking data access...

About Adverum Biotechnologies, Inc.

LSE
Market Cap
$113.10M
Shares Out.
20.98M
Sector
Health Technology
Industry
Pharmaceuticals: Major

Adverum Biotechnologies, Inc. is a clinical-stage gene therapy company that engages in the development of gene therapies for ocular and rare diseases. The company was founded by Mark S. Blumenkranz, Thomas W. Chalberg, Jr., Mitchell H. Finer, and Steven Daniel Schwartz on July 17, 2006 and is headquartered in Redwood City, CA.

www.adverum.com

Related Markets

Market Hub:Stocks Hub

Need more analysis tools?

With Alerta Chart Pro Terminal, you can follow 4 charts at the same time, see depth (order book) data and set 25 active alerts.

Start for Free
0HA3.GB (0HA3.GB) Stock Live Chart & Technical Analysis | Alerta Chart | Alerta Chart